, Tracking Stock Market Picks
Enter Symbol:
Gilead Sciences, Inc. (GILD) [hlAlert]

up 396.84 %

Gilead Sciences, Inc. (GILD) rated Buy with price target $120 by Needham

Posted on: Thursday,  Sep 25, 2014  8:25 AM ET by Needham

Needham rated Buy Gilead Sciences, Inc. (NASDAQ: GILD) on 09/25/2014. Previously Needham rated Buy Gilead Sciences, Inc. (NASDAQ: GILD) on 11/12/2008.,
when the stock price was $21.74. Since then, Gilead Sciences, Inc. has gained 396.85% as of 10/28/2015's recent price of $107.99.
If you would have followed the previous Needham's recommendation on GILD, you would have gained 396.84% of your investment in 2541 days.

Gilead Sciences, Inc. (Gilead) is a biopharmaceutical company that discovers, develops, and commercializes therapeutics in areas of unmet medical need. The Company has United States and international commercial sales operations, with marketing subsidiaries in Australia, Austria, Canada, France, Germany, Greece, Ireland, Italy, New Zealand, Portugal, Spain, Switzerland, Turkey, United Kingdom, and United States. Its commercial team promotes Truvada, Viread, Emtriva, Hepsera, AmBisome, Letairis, and Flolan through direct field contact with physicians, hospitals, clinics, and other healthcare providers. Gilead?s corporate partner, Astellas Pharma, Inc. (Astellas), promotes and sells AmBisome in the United States, Canada, Europe, Australia, and New Zealand. In May 2008, the Company acquired Navitas Assets, LLC?s. In April 2009, the Company announced the completion of its acquisition of CV Therapeutics, Inc.

Needham & Company, LLC focuses on emerging growth companies in technology, biotechnology and life sciences. The firm's research goal is to service the needs of growth-oriented institutional clients. Needham & Company has established itself as a premier specialty investment bank providing timely and valuable analysis on companies that are under-covered by the majority of Wall Street firms.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/25/2014 8:25 AM Buy
109.24 120.00
as of 10/17/2014
1 Week down  -2.87 %
1 Month down  -2.97 %
3 Months up  18.43 %
1 YTD up  34.15 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/5/2014 8:25 AM Buy
78.15 95.00
5/3/2013 9:25 AM Buy
55.87 62.00
2/5/2013 8:25 AM Buy
40.54 45.00
4/27/2012 9:25 AM Buy
26.38 28.00
2/3/2012 8:25 AM Buy
26.81 27.00
11/12/2008 9:25 AM Buy
21.74 25.50

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy